These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38408565)

  • 21. Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.
    Spreghini E; Orlando F; Sanguinetti M; Posteraro B; Giannini D; Manso E; Barchiesi F
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1215-22. PubMed ID: 22203604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel
    Hou X; Healey KR; Shor E; Kordalewska M; Ortigosa CJ; Paderu P; Xiao M; Wang H; Zhao Y; Lin LY; Zhang YH; Li YZ; Xu YC; Perlin DS; Zhao Y
    Emerg Microbes Infect; 2019; 8(1):1619-1625. PubMed ID: 31711370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Transcriptomics Approach To Unveiling the Mechanisms of
    Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
    Shen YZ; Lu HZ; Zhang YX
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
    Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
    Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital.
    Sakagami T; Kawano T; Yamashita K; Yamada E; Fujino N; Kaeriyama M; Fukuda Y; Nomura N; Mitsuyama J; Suematsu H; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2019 Jan; 25(1):34-40. PubMed ID: 30401513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transposon-sequencing (Tn-seq) of the Candida glabrata reference strain CBS138 reveals epigenetic plasticity, structural variation, and intrinsic mechanisms of resistance to micafungin.
    Nickels TJ; Gale AN; Harrington AA; Timp W; Cunningham KW
    G3 (Bethesda); 2024 Sep; 14(9):. PubMed ID: 39047065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.
    Arastehfar A; Daneshnia F; Salehi M; Yaşar M; Hoşbul T; Ilkit M; Pan W; Hagen F; Arslan N; Türk-Dağı H; Hilmioğlu-Polat S; Perlin DS; Lass-Flörl C
    Mycoses; 2020 Sep; 63(9):911-920. PubMed ID: 32413170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling.
    Nabili M; Abdollahi Gohar A; Badali H; Mohammadi R; Moazeni M
    J Glob Antimicrob Resist; 2016 Jun; 5():42-6. PubMed ID: 27436465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production.
    Samaranayake YH; Cheung BPK; Wang Y; Yau JYY; Yeung KWS; Samaranayake LP
    J Med Microbiol; 2013 Feb; 62(Pt 2):303-318. PubMed ID: 23002065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.
    Pfaller MA; Castanheira M; Lockhart SR; Ahlquist AM; Messer SA; Jones RN
    J Clin Microbiol; 2012 Apr; 50(4):1199-203. PubMed ID: 22278842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of Polymeric Amino Acid Regions in Fungal Proteins and Correlation with Altered Echinocandin and Azole Susceptibility.
    Challa K; Edlind T; Katiyar S
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Inhibitory Effect of Human Beta-defensin-3 on
    Inthanachai T; Thammahong A; Edwards SW; Virakul S; Kiatsurayanon C; Chiewchengchol D
    Immunol Invest; 2021 Jan; 50(1):80-91. PubMed ID: 32316784
    [No Abstract]   [Full Text] [Related]  

  • 37. Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.
    Samaranayake YH; Cheung BP; Yau JY; Yeung KW; Samaranayake LP
    J Investig Clin Dent; 2011 May; 2(2):117-27. PubMed ID: 25426605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates.
    Bordallo-Cardona MÁ; Marcos-Zambrano LJ; Sánchez-Carrillo C; de la Pedrosa EGG; Cantón R; Bouza E; Escribano P; Guinea J
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
    Healey KR; Nagasaki Y; Zimmerman M; Kordalewska M; Park S; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.